Overview of Helicobacter pylori Infection: Clinical Features, Treatment, and Nutritional Aspects

Merve Öztekin1, Birsen Yılmaz1,2, Duygu Ağagündüz1

  • 1Department of Nutrition and Dietetics, Faculty of Health Sciences, Gazi University, Emek, Ankara 06490, Turkey.

Insights

Helicobacter pylori (H. pylori) infection affects over half the global population, potentially leading to malnutrition. Diet, particularly high fruit and vegetable intake, may offer protection against H. pylori outcomes.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Nutrition Science

Background:

  • Helicobacter pylori (H. pylori) is a common Gram-negative bacterium causing chronic gastric infections in over 50% of the world's population.
  • Transmission routes are not fully understood but likely involve fecal-oral or oral-oral pathways through contaminated food or water.
  • H. pylori infection is linked to gastric atrophy, gastric cancer, and malabsorption of essential micronutrients, impacting malnutrition risks.

Purpose of the Study:

  • To provide a comprehensive review of Helicobacter pylori infection.
  • To explore the clinical features, treatment strategies, and nutritional aspects associated with H. pylori.
  • To highlight the role of diet in modulating H. pylori infection outcomes.

Main Methods:

  • This review synthesizes existing research on H. pylori.
  • It examines epidemiological data, pathogenicity studies, and clinical treatment outcomes.
  • Nutritional factors and their impact on H. pylori infection are analyzed.

Main Results:

  • H. pylori infection is widespread and associated with significant gastrointestinal health issues.
  • Malnutrition and micronutrient malabsorption are potential consequences of H. pylori infection.
  • Dietary interventions, including increased fruit and vegetable consumption and reduced intake of processed salty foods, show protective effects.

Conclusions:

  • H. pylori infection presents a substantial global health challenge with diverse clinical manifestations.
  • Nutrition plays a critical role in managing and potentially preventing adverse outcomes of H. pylori infection.
  • Further research into the interplay between H. pylori, host genetics, and diet is warranted for effective management strategies.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
622
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
234
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
591
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
329
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
166
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
660